B. Leder

发表

Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial

Hang Lee, R. Neer, Sherri-Ann M. Burnett-Bowie, 2013, The Lancet.

Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic men.

Hang Lee, J. Finkelstein, R. Neer, 2006, The Journal of clinical endocrinology and metabolism.

Effects of selective testosterone and estradiol withdrawal on skeletal sensitivity to parathyroid hormone in men.

J. Finkelstein, Hang Lee, B. Leder, 2006, The Journal of clinical endocrinology and metabolism.

Sarcopenia during androgen-deprivation therapy for prostate cancer.

F. Saad, T. Tammela, C. Goessl, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effects of oral androstenedione administration on serum testosterone and estradiol levels in postmenopausal women.

C. Longcope, Hang Lee, J. Finkelstein, 2002, The Journal of clinical endocrinology and metabolism.

Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels.

Hang Lee, E. A. McKay, B. Leder, 2009, The Journal of clinical endocrinology and metabolism.

Gonadal steroids and bone metabolism in men

B. Leder, 2007, Current opinion in endocrinology, diabetes, and obesity.

Osteoporosis Treatment: Sequential and Combination Therapy

J. Tsai, B. Leder, 2019, Encyclopedia of Endocrine Diseases.

Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis

B. Mitlak, G. Hattersley, R. Bockman, 2019, The Journal of clinical endocrinology and metabolism.

Bone mineral density response with denosumab in combination with standard or high-dose teriparatide: the DATA-HD RCT.

J. Tsai, B. Leder, S. Ramchand, 2020, The Journal of clinical endocrinology and metabolism.

Comparison of Denosumab and Bisphosphonates in Patients With Osteoporosis: A Meta-Analysis of Randomized Controlled Trials.

D. Solomon, S. Zhao, S. Nigwekar, 2018, The Journal of clinical endocrinology and metabolism.

Gastroenterologists and choosing the right bisphosphonate.

H. Kronenberg, B. Leder, 2000, Gastroenterology.

Two years of Denosumab and teriparatide administration in postmenopausal women with osteoporosis (The DATA Extension Study): a randomized controlled trial.

Hang Lee, R. Neer, Sherri-Ann M. Burnett-Bowie, 2014, The Journal of clinical endocrinology and metabolism.

Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer

F. Saad, T. Tammela, C. Goessl, 2012, Prostate Cancer and Prostatic Diseases.

Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis.

J. Zanchetta, G. Hattersley, B. Leder, 2015, The Journal of clinical endocrinology and metabolism.

Early Effects of Abaloparatide on Bone Formation and Resorption Indices in Postmenopausal Women With Osteoporosis

B. Mitlak, D. Dempster, Hua Zhou, 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Sclerostin Inhibition in the Treatment of Osteoporosis

R. Baron, B. Leder, F. Gori, 2020 .

Romosozumab and antiresorptive treatment: the importance of treatment sequence

E. Lewiecki, C. Libanati, D. Kendler, 2022, Osteoporosis International.

Response to Therapy With Teriparatide, Denosumab, or Both in Postmenopausal Women in the DATA (Denosumab and Teriparatide Administration) Study Randomized Controlled Trial.

R. Neer, J. Tsai, A. Uihlein, 2016, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Combination Osteoporosis Therapy with Parathyroid Hormone

B. Leder, 2015 .

Denosumab and changes in bone turnover markers during androgen deprivation therapy for prostate cancer

F. Saad, T. Tammela, C. Goessl, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effects of Teriparatide, Denosumab, or Both on Spine Trabecular Microarchitecture in DATA-Switch: a Randomized Controlled Trial.

D. Hans, Hang Lee, J. Tsai, 2017, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Comparative Resistance to Teriparatide-Induced Bone Resorption With Denosumab or Alendronate.

Hang Lee, R. Neer, Sherri-Ann M. Burnett-Bowie, 2015, The Journal of clinical endocrinology and metabolism.

Acute decline in serum sclerostin in response to PTH infusion in healthy men.

E. Yu, Ruchit Kumbhani, Erica Siwila-Sackman, 2011, The Journal of clinical endocrinology and metabolism.

Effects of teriparatide retreatment in osteoporotic men and women.

Hang Lee, H. Jüppner, J. Finkelstein, 2009, The Journal of clinical endocrinology and metabolism.

Effects of teriparatide treatment and discontinuation in postmenopausal women and eugonadal men with osteoporosis.

Hang Lee, J. Finkelstein, R. Neer, 2009, The Journal of clinical endocrinology and metabolism.

Is parathyroid hormone (1–84) a safe and effective treatment for postmenopausal osteoporosis?

B. Leder, 2007, Nature Clinical Practice Endocrinology &Metabolism.

Effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer.

F. Saad, T. Tammela, C. Goessl, 2009, The Journal of urology.

Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men.

J. Finkelstein, B. Leder, M. Fallon, 2001, The Journal of clinical endocrinology and metabolism.

Denosumab for prevention of fractures in men receiving androgen deprivation therapy (ADT) for prostate cancer (PC).

F. Saad, T. Tammela, C. Goessl, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose-Response Relationships Between Gonadal Steroids and Bone, Body Composition, and Sexual Function in Aging Men.

J. Finkelstein, Hang Lee, K. Darakananda, 2020, The Journal of clinical endocrinology and metabolism.

Gonadal steroid-dependent effects on bone turnover and bone mineral density in men.

J. Finkelstein, Hang Lee, E. Yu, 2016, The Journal of clinical investigation.

Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men

J. Finkelstein, B. Leder, 2005, Osteoporosis International.

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial

Hang Lee, R. Neer, Sherri-Ann M. Burnett-Bowie, 2015, The Lancet.

Efficacy of Zoledronic Acid in Maintaining Areal and Volumetric Bone Density After Combined Denosumab and Teriparatide Administration: DATA‐HD Study Extension

R. Eastell, Hang Lee, J. Tsai, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Differential effects of androgens and estrogens on bone turnover in normal men.

D. Schoenfeld, R. Eastell, J. Finkelstein, 2003, The Journal of clinical endocrinology and metabolism.

Effects of hPTH(1‐34) Infusion on Circulating Serum Phosphate, 1,25‐Dihydroxyvitamin D, and FGF23 Levels in Healthy Men

Hang Lee, B. Leder, S. M. Burnett-Bowie, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Teriparatide (PTH 1‐34) Treatment Increases Peripheral Hematopoietic Stem Cells in Postmenopausal Women

F. Preffer, E. Yu, Ruchit Kumbhani, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effects of gonadal steroid withdrawal on serum phosphate and FGF-23 levels in men.

B. Leder, S. M. Burnett-Bowie, Natalia Mendoza, 2007, Bone.

Importance of prompt antiresorptive therapy in postmenopausal women discontinuing teriparatide or denosumab: The Denosumab and Teriparatide Follow-up study (DATA-Follow-up).

Hang Lee, J. Tsai, B. Leder, 2017, Bone.

FSH suppression does not affect bone turnover in eugonadal men.

Hang Lee, J. Finkelstein, A. Uihlein, 2014, Journal of Clinical Endocrinology and Metabolism.

Gonadal Steroids and the Skeleton in Men

J. Finkelstein, B. Leder, 2003 .

An Essential Warning

B. Leder, 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Oral androstenedione administration and serum testosterone concentrations in young men.

D. Schoenfeld, C. Longcope, J. Finkelstein, 2000, JAMA.

Widespread disturbance in extracellular matrix collagen biomarker responses to teriparatide therapy in osteogenesis imperfecta.

M. Karsdal, Brendan H. Lee, E. Orwoll, 2020, Bone.

Fracture and Bone Mineral Density Response by Baseline Risk in Patients Treated With Abaloparatide Followed by Alendronate: Results From the Phase 3 ACTIVExtend Trial

N. Lane, G. Hattersley, A. Singer, 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Intervals between bone mineral density testing with dual-energy X-ray absorptiometry scans in clinical practice

D. Solomon, Chang Xu, S. Nigwekar, 2019, Osteoporosis International.

Gonadal steroids and body composition, strength, and sexual function in men.

J. Finkelstein, Hang Lee, J. C. Pallais, 2013, The New England journal of medicine.

Denosumab in men receiving androgen-deprivation therapy for prostate cancer.

F. Saad, T. Tammela, C. Goessl, 2009, The New England journal of medicine.

Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23.

J. Finkelstein, D. Hayden, B. Leder, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Effects of androstenedione administration on epitestosterone metabolism in men

J. Finkelstein, B. Leder, D. Catlin, 2002, Steroids.

Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs in Osteoporosis Therapy

B. Leder, 2017, Current Osteoporosis Reports.

Hyper- and Hypocalcemia

J. Finkelstein, B. Leder, 2003 .

Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial

A. Harris, J. Bilezikian, D. Hans, 2017, Osteoporosis International.

Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels.

C. Longcope, S. Rubin, B. Leder, 2004, The Journal of clinical endocrinology and metabolism.

Testosterone, estradiol and aromatase inhibitor therapy in elderly men

B. Leder, 2007, The Journal of Steroid Biochemistry and Molecular Biology.

Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels

D. Hayden, S. Rubin, B. Leder, 2005, Clinical endocrinology.

Insulin secretion and sensitivity in healthy adults with low vitamin D are not affected by high-dose ergocalciferol administration: a randomized controlled trial.

E. Cagliero, J. Finkelstein, D. Hayden, 2015, The American journal of clinical nutrition.

Relation between serum testosterone, serum estradiol, sex hormone-binding globulin, and geometrical measures of adult male proximal femur strength.

T. Travison, A. Araujo, J. Mckinlay, 2009, The Journal of clinical endocrinology and metabolism.

Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial.

R. Eastell, Hang Lee, J. Tsai, 2019, The lancet. Diabetes & endocrinology.

A Lot of Progress, With More to Be Done: A Response to NIH Pathways to Prevention Report “Research Gaps for Long‐Term Drug Therapies for Osteoporotic Fracture Prevention”

D. Kiel, S. Khosla, E. Shane, 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Anabolic therapies for osteoporosis.

A. Uihlein, B. Leder, Alexander V Uihlein, 2012, Endocrinology and metabolism clinics of North America.

Androgens and the Skeleton – Humans

B. Leder, 2010 .

Combination and Sequential Osteoanabolic/Antiresorptive Therapy in Osteoporosis Treatment

B. Leder, 2020 .

Optimizing Sequential and Combined Anabolic and Antiresorptive Osteoporosis Therapy

B. Leder, 2018, JBMR plus.

Trace contamination of over-the-counter androstenedione and positive urine test results for a nandrolone metabolite.

J. Finkelstein, B. Leder, D. Catlin, 2000, JAMA.

Effects of Combination Denosumab and High‐Dose Teriparatide Administration on Bone Microarchitecture and Estimated Strength: The DATA‐HD HR‐pQCT Study

M. Bouxsein, Hang Lee, J. Tsai, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effects of Denosumab and Teriparatide Transitions on Bone Microarchitecture and Estimated Strength: the DATA‐Switch HR‐pQCT study

Mary L Bouxsein, M. Bouxsein, Hang Lee, 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study).

M. Bouxsein, R. Neer, N. Derrico, 2016, The Journal of clinical endocrinology and metabolism.

Comparative Effects of Teriparatide, Denosumab, and Combination Therapy on Peripheral Compartmental Bone Density, Microarchitecture, and Estimated Strength: the DATA‐HRpQCT Study

M. Bouxsein, Hang Lee, R. Neer, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Combination Anabolic and Antiresorptive Therapy for Osteoporosis

J. Tsai, B. Leder, 2018, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism.

Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use.

D. Solomon, S. Zhao, S. Nigwekar, 2019, The Journal of clinical endocrinology and metabolism.

The Effect of Zoledronic Acid on Bone Microarchitecture and Strength after Denosumab and Teriparatide Administration: DATA‐HD Study Extension

M. Bouxsein, Hang Lee, J. Tsai, 2022, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

What Else Do We Need? A Commentary on Zoledronate Effects on Cancer and Cardiac Events

B. Leder, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Letter to the editor in response to the commentary, "Concurrent administration of PTH and antiresorptives: Additive effects or DXA cosmetics.

M. Bouxsein, R. Neer, J. Tsai, 2016, Bone.

Correlations between serum testosterone, estradiol, and sex hormone-binding globulin and bone mineral density in a diverse sample of men.

T. Travison, A. Araujo, J. Mckinlay, 2008, The Journal of clinical endocrinology and metabolism.

Racial and ethnic differences in bone turnover markers in men.

T. Travison, A. Araujo, J. Mckinlay, 2007, The Journal of clinical endocrinology and metabolism.

Relationship between bone turnover and density with teriparatide, denosumab or both in women in the DATA study.

J. Tsai, B. Leder, S. M. Burnett-Bowie, 2017, Bone.

Delayed Denosumab Injections and Bone Mineral Density Response: An Electronic Health Record-based Study.

D. Solomon, S. Zhao, S. Nigwekar, 2020, The Journal of clinical endocrinology and metabolism.

Effects of aromatase inhibition in hypogonadal older men: a randomized, double‐blind, placebo‐controlled trial

Hang Lee, B. Leder, S. M. Burnett-Bowie, 2009, Clinical endocrinology.

Delayed Denosumab Injections and Fracture Risk Among Patients With Osteoporosis

D. Solomon, S. Zhao, C. Zeng, 2020, Annals of Internal Medicine.

Effects of escitalopram on markers of bone turnover: a randomized clinical trial.

A. LaCroix, K. Ensrud, E. Freeman, 2014, The Journal of clinical endocrinology and metabolism.

EFFECTS OF TWICE-YEARLY SUBCUTANEOUS DENOSUMAB ON BONE MINERAL DENSITY IN MEN RECEIVING ANDROGEN-DEPRIVATION THERAPY FOR NON-METASTATIC PROSTATE CANCER

C. Goessl, B. Leder, Matthew R. Smith, 2009 .

7005 Overall survival in men with and without prevalent vertebral fracture receiving androgen deprivation therapy for nonmetastatic prostate cancer

F. Saad, T. Tammela, C. Goessl, 2009 .